|Articles|May 1, 2011
- Pharmaceutical Executive-05-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - May 2011
Sizing Up For Success
Advertisement
Articles in this issue
almost 15 years ago
Malaysia: The Overlooked Emerging Marketalmost 15 years ago
High-Risks to High Rewardalmost 15 years ago
UK Stakeholders Have Their Say on Value-Based Pricingalmost 15 years ago
Expanded Liability for Generic, Brand Manufacturers Ahead?almost 15 years ago
Using Social Networks to Guide Product Spendalmost 15 years ago
iDeal Tool of Sales Tradealmost 15 years ago
The Elusive Single-Point-of-Entryalmost 15 years ago
Outrage Over Drug Pricesalmost 15 years ago
Seeing Through the Transparency Directivealmost 15 years ago
On Tour with Merck's RobotsNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
3
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science
4
FDA Sends Warning Letter to ImmunityBio for Misleading Claims in Advertisement
5